{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:28:12Z","timestamp":1793852892912,"version":"4.6.1"},"reference-count":189,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972313"],"award-info":[{"award-number":["81972313"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["KFB2020003.3"],"award-info":[{"award-number":["KFB2020003.3"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbcan.2025.189433","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:47:07Z","timestamp":1756482427000},"page":"189433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Role of mesenchymal stem cells in modulating cytokine networks and immune checkpoints in gastric cancer therapy"],"prefix":"10.1016","volume":"1880","author":[{"given":"Zakari","family":"Shaibu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isah Adamu","family":"Danbala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbcan.2025.189433_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189433_bb0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0015","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob. Health"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189433_bb0020","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","article-title":"Burden of gastric cancer","volume":"18","author":"Thrift","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189433_bb0025","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-S","article-title":"The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the \u201cdifferent disease\u201d hypothesis","volume":"88","author":"Hundahl","year":"2000","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189433_bb0030","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S1470-2045(17)30566-1","article-title":"Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"18","author":"Catenacci","year":"2017","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189433_bb0035","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1470-2045(18)30791-5","article-title":"Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Fuchs","year":"2019","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189433_bb0040","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1470-2045(13)70102-5","article-title":"Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial","volume":"14","author":"Lordick","year":"2013","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189433_bb0045","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jamaoncol.2016.5580","article-title":"Effect of fluorouracil, Leucovorin, and Oxaliplatin with or without Onartuzumab in HER2-negative, MET-positive gastroesophageal adenocarcinoma: the METGastric randomized clinical trial","volume":"3","author":"Shah","year":"2017","journal-title":"JAMA Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0050","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric Cancer, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"37","key":"10.1016\/j.bbcan.2025.189433_bb0055","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1038\/s41388-020-01390-0","article-title":"DOCK6 promotes chemo- and radioresistance of gastric cancer by modulating WNT\/\u03b2-catenin signaling and cancer stem cell traits","volume":"39","author":"Chi","year":"2020","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189433_bb0060","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1517\/14712598.2016.1164137","article-title":"Monoclonal antibodies for treating gastric cancer: promises and pitfalls","volume":"16","author":"Sibertin-Blanc","year":"2016","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189433_bb0065","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.celrep.2019.04.052","article-title":"Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer","volume":"27","author":"Zhang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2025.189433_bb0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.semcancer.2019.06.003","article-title":"The multifaceted role of mesenchymal stem cells in cancer","volume":"60","author":"Timaner","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2016.193","article-title":"Tumour-associated mesenchymal stem\/stromal cells: emerging therapeutic targets","volume":"16","author":"Shi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.molcel.2012.06.020","article-title":"Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells","volume":"47","author":"Tsai","year":"2012","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189433_bb0085","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1634\/stemcells.2007-0197","article-title":"Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing","volume":"25","author":"Chamberlain","year":"2007","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41392-021-00488-5","article-title":"Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"6","author":"Shi","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2025.189433_bb0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.canlet.2020.05.005","article-title":"Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins","volume":"484","author":"Galland","year":"2020","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189433_bb0100","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1016\/j.celrep.2017.08.089","article-title":"Tumor-derived mesenchymal stem cells use distinct mechanisms to block the activity of natural killer cell subsets","volume":"20","author":"Galland","year":"2017","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189433_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41389-018-0049-3","article-title":"Tumor-derived exosomes induce PD1(+) macrophage population in human gastric cancer that promotes disease progression","volume":"7","author":"Wang","year":"2018","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","article-title":"Cytokines in cancer pathogenesis and cancer therapy","volume":"4","author":"Dranoff","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189433_bb0115","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.annonc.2021.09.010","article-title":"Harmful cytokines in cancer immunology and immunotherapy: biomarkers and targets?","volume":"32","author":"Melero","year":"2021","journal-title":"Ann. Oncol."},{"issue":"10142","key":"10.1016\/j.bbcan.2025.189433_bb0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(18)31257-1","article-title":"Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial","volume":"392","author":"Shitara","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13046-015-0172-3","article-title":"Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8","volume":"34","author":"Li","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189433_bb0130","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jcyt.2019.08.002","article-title":"Mesenchymal stem versus stromal cells: International Society for Cell & gene therapy (ISCT\u00ae) mesenchymal stromal cell committee position statement on nomenclature","volume":"21","author":"Viswanathan","year":"2019","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189433_bb0135","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189433_bb0140","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.stem.2012.08.013","article-title":"CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNF\u03b1","volume":"11","author":"Ren","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"13","key":"10.1016\/j.bbcan.2025.189433_bb0145","doi-asserted-by":"crossref","first-page":"16567","DOI":"10.18632\/oncotarget.7767","article-title":"miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-\u03baB p65 activation","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189433_bb0150","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41419-018-0988-9","article-title":"Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3\/mTOR-c-Myc signal axis","volume":"9","author":"Sun","year":"2018","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0155","first-page":"83","article-title":"Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method","volume":"2","author":"Friedenstein","year":"1974","journal-title":"Exp. Hematol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0160","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2007.08.025","article-title":"Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment","volume":"131","author":"Sacchetti","year":"2007","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.bbcan.2025.189433_bb0165","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/jnci\/djh299","article-title":"Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents","volume":"96","author":"Studeny","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"issue":"30","key":"10.1016\/j.bbcan.2025.189433_bb0170","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1038\/onc.2013.387","article-title":"Tumor resident mesenchymal stromal cells endow na\u00efve stromal cells with tumor-promoting properties","volume":"33","author":"Ren","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0175","first-page":"747","article-title":"Macrophages activate mesenchymal stem cells to acquire cancer-associated fibroblast-like features resulting in gastric epithelial cell lesions and malignant transformation in vitro","volume":"17","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189433_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097569","article-title":"Activation of mesenchymal stem cells by macrophages prompts human gastric cancer growth through NF-\u03baB pathway","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189433_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9501747","article-title":"Human bone marrow mesenchymal stem cells promote gastric cancer growth via regulating c-Myc","volume":"2018","author":"Chen","year":"2018","journal-title":"Stem Cells Int."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189433_bb0190","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.3892\/mmr.2016.5625","article-title":"Exosomes derived from human mesenchymal stem cells promote gastric cancer cell growth and migration via the activation of the Akt pathway","volume":"14","author":"Gu","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189433_bb0195","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/bjc.2014.14","article-title":"Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer","volume":"110","author":"Wang","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189433_bb0200","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s13577-020-00339-5","article-title":"Gastric-cancer-derived mesenchymal stem cells: a promising target for resveratrol in the suppression of gastric cancer metastasis","volume":"33","author":"Yin","year":"2020","journal-title":"Hum. Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.yexcr.2017.09.036","article-title":"Gastric cancer tissue-derived mesenchymal stem cells impact peripheral blood mononuclear cells via disruption of Treg\/Th17 balance to promote gastric cancer progression","volume":"361","author":"Wang","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbcan.2025.189433_bb0210","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9989790","article-title":"Gastric cancer mesenchymal stem cells inhibit NK cell function through mTOR Signalling to promote tumour growth","volume":"2021","author":"Guo","year":"2021","journal-title":"Stem Cells Int."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189433_bb0215","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/cas.12871","article-title":"Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis","volume":"107","author":"Takiguchi","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2025.189433_bb0220","article-title":"G6PD-NF-\u03baB-HGF signal in gastric Cancer-associated mesenchymal stem cells promotes the proliferation and metastasis of gastric cancer cells by upregulating the expression of HK2","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10120-012-0166-1","article-title":"Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells","volume":"16","author":"Zhu","year":"2013","journal-title":"Gastric Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189433_bb0230","first-page":"1178","article-title":"Study of inhibiting and killing effects of transgenic LIGHT human umbilical cord blood mesenchymal stem cells on stomach cancer","volume":"15","author":"Ma","year":"2012","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0235","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3892\/ijmm.2014.2019","article-title":"Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells","volume":"35","author":"Wang","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189433_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113697","article-title":"FAP+ gastric cancer mesenchymal stromal cells via paracrining INHBA and remodeling ECM promote tumor progression","volume":"144","author":"Liu","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"37","key":"10.1016\/j.bbcan.2025.189433_bb0245","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/onc.2012.458","article-title":"Mesenchymal stem cells promote growth and angiogenesis of tumors in mice","volume":"32","author":"Huang","year":"2013","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189433_bb0250","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s12015-024-10720-8","article-title":"Gastric cancer mesenchymal stem cells trigger endothelial cell functional changes to promote cancer progression","volume":"20","author":"Cui","year":"2024","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.bbcan.2025.189433_bb0255","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8071842","article-title":"The emerging role of GC-MSCs in the gastric cancer microenvironment: from tumor to tumor immunity","volume":"2019","author":"Pan","year":"2019","journal-title":"Stem Cells Int."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189433_bb0260","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3892\/or.2017.5831","article-title":"miR-374 mediates the malignant transformation of gastric cancer-associated mesenchymal stem cells in an experimental rat model","volume":"38","author":"Ji","year":"2017","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189433_bb0265","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3892\/ijmm.2013.1532","article-title":"H. Pylori infection-induced MSC differentiation into CAFs promotes epithelial-mesenchymal transition in gastric epithelial cells","volume":"32","author":"Zhang","year":"2013","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189433_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061350","article-title":"Isoliquiritigenin inhibits gastric cancer Stemness, modulates tumor microenvironment, and suppresses tumor growth through glucose-regulated protein 78 downregulation","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189433_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052465","article-title":"Gastric cancer exosomes trigger differentiation of umbilical cord derived mesenchymal stem cells to carcinoma-associated fibroblasts through TGF-\u03b2\/Smad pathway","volume":"7","author":"Gu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189433_bb0280","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molimm.2025.01.005","article-title":"Gastric cancer mesenchymal stem cells upregulate PD-1 expression on the CD8(+) T cells by regulating the PI3K\/AKT pathway","volume":"178","author":"Ji","year":"2025","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0285","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1074\/jbc.M111.294355","volume":"287","author":"Diegelmann","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0290","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2008.10.018","article-title":"RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F","volume":"136","author":"Leppkes","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0295","first-page":"534","article-title":"IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis","volume":"118","author":"Sugimoto","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"260","key":"10.1016\/j.bbcan.2025.189433_bb0300","article-title":"The Jak-STAT pathway stimulated by interferon gamma","volume":"2004","author":"Horvath","year":"2004","journal-title":"Sci. STKE"},{"issue":"260","key":"10.1016\/j.bbcan.2025.189433_bb0305","article-title":"The Jak-STAT pathway stimulated by interferon alpha or interferon beta","volume":"2004","author":"Horvath","year":"2004","journal-title":"Sci. STKE"},{"issue":"260","key":"10.1016\/j.bbcan.2025.189433_bb0310","article-title":"The Jak-STAT pathway stimulated by interleukin 6","volume":"2004","author":"Horvath","year":"2004","journal-title":"Sci. STKE"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189433_bb0315","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cyto.2008.07.017","article-title":"An overview of IL-17 function and signaling","volume":"43","author":"Gaffen","year":"2008","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0320","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/bjo.80.1.63","article-title":"Effects of the cytokines on the proliferation of and collagen synthesis by human cataract lens epithelial cells","volume":"80","author":"Nishi","year":"1996","journal-title":"Br. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189433_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.201","article-title":"Luteolin-7-glucoside inhibits IL-22\/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model","volume":"7","author":"Palombo","year":"2016","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189433_bb0330","first-page":"C498","article-title":"TNF-\u03b1 augments RANKL-dependent intestinal M cell differentiation in enteroid cultures","volume":"311","author":"Wood","year":"2016","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189433_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5070063","article-title":"Mechanisms of TGF\u03b2-induced epithelial-mesenchymal transition","volume":"5","author":"Moustakas","year":"2016","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0340","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.yexcr.2016.05.004","article-title":"Interleukin 22 early affects keratinocyte differentiation, but not proliferation, in a three-dimensional model of normal human skin","volume":"345","author":"Donetti","year":"2016","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189433_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095993","article-title":"Inhibition of the JAK2\/STAT3 pathway reduces gastric cancer growth in vitro and in vivo","volume":"9","author":"Judd","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189433_bb0350","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0355","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/147323000303100202","article-title":"Expression of interleukin 6 and its receptor in human gastric and colorectal cancers","volume":"31","author":"Matsuo","year":"2003","journal-title":"J. Int. Med. Res."},{"issue":"13","key":"10.1016\/j.bbcan.2025.189433_bb0360","doi-asserted-by":"crossref","first-page":"20741","DOI":"10.18632\/oncotarget.15119","article-title":"IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2\/STAT3 signaling pathway","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189433_bb0365","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41419-024-07100-y","article-title":"Correction to: the IL-6-STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression","volume":"15","author":"Zhu","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189433_bb0370","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6270784","article-title":"Role of cancer-associated fibroblast in gastric cancer progression and resistance to treatments","volume":"2019","author":"Ham","year":"2019","journal-title":"J. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0375","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s10120-005-0315-x","article-title":"Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor","volume":"8","author":"Ashizawa","year":"2005","journal-title":"Gastric Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0380","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1158\/1078-0432.CCR-07-1032","article-title":"Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma","volume":"14","author":"Liao","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"51","key":"10.1016\/j.bbcan.2025.189433_bb0385","doi-asserted-by":"crossref","first-page":"29820","DOI":"10.18632\/oncotarget.25661","article-title":"Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer","volume":"9","author":"Vainer","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0390","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/path.2218","article-title":"Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression","volume":"213","author":"Jackson","year":"2007","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189433_bb0395","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/07357907.2019.1638395","article-title":"Interleukin-6 receptor (IL-6R) expression in human gastric carcinoma and its clinical significance","volume":"37","author":"Simondurairaj","year":"2019","journal-title":"Cancer Investig."},{"key":"10.1016\/j.bbcan.2025.189433_bb0400","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/1471-2407-10-419","article-title":"Involvement of tumor necrosis factor-alpha in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori","volume":"10","author":"Zhao","year":"2010","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0405","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","article-title":"Tumor necrosis factor signaling","volume":"10","author":"Wajant","year":"2003","journal-title":"Cell Death Differ."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189433_bb0410","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1745-7254.2008.00889.x","article-title":"Tumor necrosis factor and cancer, buddies or foes?","volume":"29","author":"Wang","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"issue":"19","key":"10.1016\/j.bbcan.2025.189433_bb0415","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-11-0482","article-title":"The two faces of interferon-\u03b3 in cancer","volume":"17","author":"Zaidi","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189433_bb0420","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bbcan.2025.189433_bb0425","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189433_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer immune evasion through loss of MHC class I antigen presentation","volume":"12","author":"Dhatchinamoorthy","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189433_bb0435","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1158\/0008-5472.CAN-10-4009","article-title":"IFN-\u03b3 inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis","volume":"71","author":"Tu","year":"2011","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0440","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/cas.13424","article-title":"PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer","volume":"109","author":"Mimura","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2025.189433_bb0445","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0450","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cyto.2013.07.022","article-title":"IL-17 family: cytokines, receptors and signaling","volume":"64","author":"Gu","year":"2013","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0455","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190297","article-title":"The role of interleukin-17 in tumor development and progression","volume":"217","author":"Zhao","year":"2020","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189433_bb0460","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1007\/s12032-012-0273-1","article-title":"Expression of interleukin-17 and its clinical significance in gastric cancer patients","volume":"29","author":"Meng","year":"2012","journal-title":"Med. Oncol."},{"issue":"14","key":"10.1016\/j.bbcan.2025.189433_bb0465","doi-asserted-by":"crossref","first-page":"877","DOI":"10.21037\/atm-20-4843","article-title":"Cancer-associated fibroblasts promote the migration and invasion of gastric cancer cells via activating IL-17a\/JAK2\/STAT3 signaling","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189433_bb0470","first-page":"1601","article-title":"Serum IL-17 levels can be diagnostic for gastric cancer","volume":"24","author":"Karabulut","year":"2019","journal-title":"J. BUON"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189433_bb0475","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s10571-009-9409-z","article-title":"IL-17 stimulates migration of carotid artery vascular smooth muscle cells in an MMP-9 dependent manner via p38 MAPK and ERK1\/2-dependent NF-kappaB and AP-1 activation","volume":"29","author":"Cheng","year":"2009","journal-title":"Cell. Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189433_bb0480","article-title":"Interleukin 17A promotes gastric cancer invasiveness via NF-\u03baB mediated matrix metalloproteinases 2 and 9 expression","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"5\u20136","key":"10.1016\/j.bbcan.2025.189433_bb0485","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1387\/ijdb.041811af","article-title":"Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies","volume":"48","author":"Folgueras","year":"2004","journal-title":"Int. J. Dev. Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189433_bb0490","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1007\/s13277-015-4372-4","article-title":"IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer","volume":"37","author":"Wu","year":"2016","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0495","first-page":"137","article-title":"Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers","volume":"49","author":"Laz\u0103r","year":"2008","journal-title":"Romanian J. Morphol. Embryol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189433_bb0500","first-page":"10515","article-title":"Prognostic significance of interleukin-17 in solid tumors: a meta-analysis","volume":"8","author":"Zeng","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0505","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7150\/ijbs.7.53","article-title":"Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients","volume":"7","author":"Chen","year":"2011","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0510","first-page":"595","article-title":"IL-10 secreted by cancer-associated macrophages regulates proliferation and invasion in gastric cancer cells via c-Met\/STAT3 signaling","volume":"42","author":"Chen","year":"2019","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0515","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s10120-015-0591-z","article-title":"CD4(+) regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-\u03b2","volume":"20","author":"Kindlund","year":"2017","journal-title":"Gastric Cancer"},{"issue":"2\u20133","key":"10.1016\/j.bbcan.2025.189433_bb0520","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12026-011-8262-6","article-title":"Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy","volume":"51","author":"Sato","year":"2011","journal-title":"Immunol. Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189433_bb0525","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S1470-2045(12)70582-X","article-title":"Cytokine patterns in patients with cancer: a systematic review","volume":"14","author":"Lippitz","year":"2013","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189433_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139598","article-title":"Serum IL-10 predicts worse outcome in cancer patients: a meta-analysis","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189433_bb0535","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/infdis\/jiv467","article-title":"Helicobacter pylori cagA promoter region sequences influence CagA expression and interleukin 8 secretion","volume":"213","author":"Ferreira","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0540","first-page":"1036","article-title":"Complementary action of CXCL1 and CXCL8 in pathogenesis of gastric carcinoma","volume":"11","author":"Chen","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbcan.2025.189433_bb0545","first-page":"27","article-title":"Human and Helicobacter pylori interactions determine the outcome of gastric diseases","volume":"400","author":"Gobert","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0550","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/ijo.2015.3234","article-title":"IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (review)","volume":"48","author":"Long","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0555","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12032-010-9780-0","article-title":"Interleukin-8 is associated with adhesion, migration and invasion in human gastric cancer SCG-7901 cells","volume":"29","author":"Ju","year":"2012","journal-title":"Med. Oncol."},{"issue":"18","key":"10.1016\/j.bbcan.2025.189433_bb0560","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1158\/0008-5472.CAN-14-3690","article-title":"Loss of RACK1 promotes metastasis of gastric cancer by inducing a miR-302c\/IL8 signaling loop","volume":"75","author":"Chen","year":"2015","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189433_bb0565","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0570","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.beha.2011.01.002","article-title":"Mesenchymal stem cells and autoimmune diseases","volume":"24","author":"Dazzi","year":"2011","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0575","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/187152809788462635","article-title":"Treatment of inflammatory diseases with mesenchymal stem cells","volume":"8","author":"Newman","year":"2009","journal-title":"Inflamm. Allergy Drug Targets"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189433_bb0580","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.copbio.2012.05.005","article-title":"Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases","volume":"23","author":"DelaRosa","year":"2012","journal-title":"Curr. Opin. Biotechnol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0585","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/cdd.2013.158","article-title":"Immunobiology of mesenchymal stem cells","volume":"21","author":"Ma","year":"2014","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189433_bb0590","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/cr.2010.44","article-title":"Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair","volume":"20","author":"Shi","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2025.189433_bb0595","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/295167","article-title":"Conditioned medium from adipose tissue-derived mesenchymal stem cells induces CD4+FOXP3+ cells and increases IL-10 secretion","volume":"2012","author":"Ivanova-Todorova","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0600","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/157488810791268564","article-title":"Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine","volume":"5","author":"Salgado","year":"2010","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.bbcan.2025.189433_bb0605","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1479-5876-10-172","article-title":"Analysis of in vitro secretion profiles from adipose-derived cell populations","volume":"10","author":"Blaber","year":"2012","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0610","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.molmed.2011.10.004","article-title":"The immunomodulatory capacity of mesenchymal stem cells","volume":"18","author":"Gebler","year":"2012","journal-title":"Trends Mol. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189433_bb0615","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/jcp.21068","article-title":"Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors","volume":"212","author":"Kilroy","year":"2007","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189433_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057892","article-title":"Differences in gene expression and cytokine release profiles highlight the heterogeneity of distinct subsets of adipose tissue-derived stem cells in the subcutaneous and visceral adipose tissue in humans","volume":"8","author":"Perrini","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0625","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15283\/ijsc.2009.2.1.59","article-title":"Cytokine secretion profiling of human mesenchymal stem cells by antibody array","volume":"2","author":"Park","year":"2009","journal-title":"Int. J. Stem Cells"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189433_bb0630","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrrheum.2009.104","article-title":"Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases","volume":"5","author":"Djouad","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189433_bb0635","first-page":"968","article-title":"Human adipose derived stem cells do not Alter cytokine secretion in response to the genetic modification with pEGFP-N2 plasmid DNA","volume":"26","author":"Solovyeva","year":"2013","journal-title":"World Appl. Sci. J."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4252\/wjsc.v3.i1.1","article-title":"Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand?","volume":"3","author":"Bassi","year":"2011","journal-title":"World J. Stem Cells"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189433_bb0645","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4252\/wjsc.v6.i5.552","article-title":"Secretion of immunoregulatory cytokines by mesenchymal stem cells","volume":"6","author":"Kyurkchiev","year":"2014","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.bbcan.2025.189433_bb0650","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fimmu.2014.00148","article-title":"The life and fate of mesenchymal stem cells","volume":"5","author":"Eggenhofer","year":"2014","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2025.189433_bb0655","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.imlet.2009.07.010","article-title":"Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells","volume":"126","author":"Ivanova-Todorova","year":"2009","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0660","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/cas.12313","article-title":"Interleukin-6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3","volume":"105","author":"Cui","year":"2014","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0665","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","article-title":"Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways","volume":"19","author":"Kraehenbuehl","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6382","key":"10.1016\/j.bbcan.2025.189433_bb0670","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0675","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","article-title":"Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential","volume":"161","author":"Sharma","year":"2015","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189433_bb0680","first-page":"299","article-title":"Immune checkpoint inhibitors win the 2018 Nobel prize","volume":"42","author":"Huang","year":"2019","journal-title":"Biom. J."},{"issue":"Suppl. 2","key":"10.1016\/j.bbcan.2025.189433_bb0685","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3747\/co.27.5223","article-title":"A review of cancer immunotherapy: from the past, to the present, to the future","volume":"27","author":"Esfahani","year":"2020","journal-title":"Curr. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189433_bb0690","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/curroncol29050247","article-title":"Immune checkpoint inhibitors in Cancer therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Curr. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189433_bb0695","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2025.189433_bb0700","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ctrv.2018.04.004","article-title":"Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: current status and future perspectives","volume":"66","author":"Taieb","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"14","key":"10.1016\/j.bbcan.2025.189433_bb0705","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1158\/1078-0432.CCR-20-0075","article-title":"The impact of molecular subtype on efficacy of chemotherapy and checkpoint inhibition in advanced gastric cancer","volume":"26","author":"Kubota","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189433_bb0710","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/j.seminoncol.2010.09.015","article-title":"Development of ipilimumab: contribution to a new paradigm for cancer immunotherapy","volume":"37","author":"Hoos","year":"2010","journal-title":"Semin. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189433_bb0715","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124427","article-title":"Combination of Ipilimumab and Nivolumab in cancers: from clinical practice to ongoing clinical trials","volume":"21","author":"Kooshkaki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.bbcan.2025.189433_bb0720","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"34","key":"10.1016\/j.bbcan.2025.189433_bb0725","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1200\/JCO.2016.67.2477","article-title":"Programmed Death-Ligand 1 expression and response to the anti\u2013programmed Death 1 Antibody Pembrolizumab in Melanoma","volume":"34","author":"Daud","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"10294","key":"10.1016\/j.bbcan.2025.189433_bb0730","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189433_bb0735","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1158\/2326-6066.CIR-22-0218","article-title":"DKK1 promotes tumor immune evasion and impedes anti-PD-1 treatment by inducing immunosuppressive macrophages in gastric cancer","volume":"10","author":"Shi","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2025.189433_bb0740","article-title":"Recent progress and future perspectives of immunotherapy in advanced gastric cancer","volume":"13","author":"Jin","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0745","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jss.2004.06.011","article-title":"Usefulness of inhibiting the lymph node metastasis in human gastric carcinoma by B7-1 gene transfection","volume":"122","author":"Sakate","year":"2004","journal-title":"J. Surg. Res."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189433_bb0750","doi-asserted-by":"crossref","first-page":"568","DOI":"10.7150\/ijbs.39769","article-title":"Comprehensive understanding of B7 family in gastric cancer: expression profile, association with clinicopathological parameters and downstream targets","volume":"16","author":"Li","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189433_bb0755","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1200\/JCO.2018.78.2276","article-title":"T-cell-inflamed gene-expression profile, programmed death ligand 1 expression, and tumor mutational burden predict efficacy in patients treated with Pembrolizumab across 20 cancers: KEYNOTE-028","volume":"37","author":"Ott","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189433_bb0760","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189433_bb0765","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113414","article-title":"Gastric cancer-derived mesenchymal stem cells promote gastric cancer cell lines migration by modulating CD276 expression","volume":"422","author":"Gao","year":"2023","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189433_bb0775","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/annonc\/mdy264","article-title":"Phase III, randomised trial of avelumab versus physician\u2019s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN gastric 300","volume":"29","author":"Bang","year":"2018","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189433_bb0780","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.it.2018.05.001","article-title":"Defining and understanding adaptive resistance in cancer immunotherapy","volume":"39","author":"Kim","year":"2018","journal-title":"Trends Immunol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189433_bb0785","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1158\/1078-0432.CCR-16-1761","article-title":"PD-L2 expression in human tumors: relevance to anti-PD-1 therapy in cancer","volume":"23","author":"Yearley","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189433_bb0790","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","article-title":"Mesenchymal stem cell perspective: cell biology to clinical progress","volume":"4","author":"Pittenger","year":"2019","journal-title":"NPJ Regen. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0795","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2025.189433_bb0800","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2820853","article-title":"Mesenchymal stem cells and cancer: clinical challenges and opportunities","volume":"2019","author":"Lin","year":"2019","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0805","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","article-title":"The secretion profile of mesenchymal stem cells and potential applications in treating human diseases","volume":"7","author":"Han","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"13","key":"10.1016\/j.bbcan.2025.189433_bb0810","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1158\/0008-5472.CAN-11-4094","article-title":"Cellular constituents of immune escape within the tumor microenvironment","volume":"72","author":"Kerkar","year":"2012","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189433_bb0815","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and Cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189433_bb0820","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189433_bb0825","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1073\/pnas.0806647106","article-title":"Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy","volume":"106","author":"Sasportas","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"19","key":"10.1016\/j.bbcan.2025.189433_bb0830","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-18-0205","article-title":"Cancer-associated fibroblasts affect Intratumoral CD8(+) and FoxP3(+) T cells via IL6 in the tumor microenvironment","volume":"24","author":"Kato","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"7693","key":"10.1016\/j.bbcan.2025.189433_bb0835","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189433_bb0840","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.ymthe.2017.02.007","article-title":"Exosomes from M1-polarized macrophages potentiate the cancer vaccine by creating a pro-inflammatory microenvironment in the lymph node","volume":"25","author":"Cheng","year":"2017","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0845","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1158\/2159-8290.CD-17-0787","article-title":"Genetic predictors of response to systemic therapy in Esophagogastric cancer","volume":"8","author":"Janjigian","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2025.189433_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115405","article-title":"Role of cancer-educated mesenchymal stromal cells on tumor progression","volume":"166","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0855","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","article-title":"IL-6 and related cytokines as the critical lynchpins between inflammation and cancer","volume":"26","author":"Taniguchi","year":"2014","journal-title":"Semin. Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189433_bb0860","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF02256101","article-title":"Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma","volume":"11","author":"Huang","year":"2004","journal-title":"J. Biomed. Sci."},{"issue":"21","key":"10.1016\/j.bbcan.2025.189433_bb0865","doi-asserted-by":"crossref","first-page":"16042","DOI":"10.1074\/jbc.M110.111054","article-title":"Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2\/ERK and JAK\/STAT signal transduction pathways in gastric epithelial cells","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"29","key":"10.1016\/j.bbcan.2025.189433_bb0870","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1038\/onc.2013.356","article-title":"TNF-\u03b1\/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells","volume":"33","author":"Oshima","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189433_bb0875","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5801209","article-title":"Reactive oxygen species-mediated tumor microenvironment transformation: the mechanism of Radioresistant gastric cancer","volume":"2018","author":"Gu","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189433_bb0880","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13030181","article-title":"Role of TNF-\u03b1-inducing protein secreted by helicobacter pylori as a tumor promoter in gastric cancer and emerging preventive strategies","volume":"13","author":"Suganuma","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0885","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cyto.2014.07.005","article-title":"Association between TNF-\u03b1-308 G\/A gene polymorphism and gastric cancer risk: a systematic review and meta-analysis","volume":"70","author":"Yang","year":"2014","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0890","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3892\/br.2017.934","article-title":"The relationship between tumor necrosis factor-\u03b1 polymorphisms and gastric cancer risk: an updated meta-analysis","volume":"7","author":"Zheng","year":"2017","journal-title":"Biomed. Rep."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189433_bb0895","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/onc.2016.291","article-title":"The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms","volume":"36","author":"Jiang","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0900","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13046-018-1003-0","article-title":"Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells","volume":"38","author":"Li","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189433_bb0905","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1158\/1078-0432.CCR-16-0617","article-title":"Interleukin-17-producing neutrophils link inflammatory stimuli to disease progression by promoting angiogenesis in gastric cancer","volume":"23","author":"Li","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189433_bb0910","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.canlet.2015.07.009","article-title":"The paradoxical role of IL-10 in immunity and cancer","volume":"367","author":"Mannino","year":"2015","journal-title":"Cancer Lett."},{"issue":"21","key":"10.1016\/j.bbcan.2025.189433_bb0915","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"45","key":"10.1016\/j.bbcan.2025.189433_bb0920","doi-asserted-by":"crossref","first-page":"8192","DOI":"10.3748\/wjg.v19.i45.8192","article-title":"Helicobacter pylori and interleukin-8 in gastric cancer","volume":"19","author":"Lee","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189433_bb0925","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1136\/gutjnl-2018-316324","article-title":"Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer","volume":"68","author":"Lin","year":"2019","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189433_bb0930","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0959-8049(01)00147-2","article-title":"Interleukin 8 and vascular endothelial growth factor -- prognostic factors in human gastric carcinomas?","volume":"37","author":"Kido","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189433_bb0935","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10120-023-01405-1","article-title":"Gastric cancer mesenchymal stem cells via the CXCR2\/HK2\/PD-L1 pathway mediate immunosuppression","volume":"26","author":"Huang","year":"2023","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189433_bb0940","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/jir.2018.0087","article-title":"The interferon-gamma paradox in cancer","volume":"39","author":"Zaidi","year":"2019","journal-title":"J. Interf. Cytokine Res."},{"issue":"6127","key":"10.1016\/j.bbcan.2025.189433_bb0945","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/328267a0","article-title":"A new member of the immunoglobulin superfamily--CTLA-4","volume":"328","author":"Brunet","year":"1987","journal-title":"Nature"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:02:35Z","timestamp":1777554155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25001751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":189,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0304419X25001751"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189433","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of mesenchymal stem cells in modulating cytokine networks and immune checkpoints in gastric cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189433"}}